Coronavirus Precautions: Experience of High Volume Liver Transplant Institute

dc.authoridYilmaz, Sezai/0000-0002-8044-0297
dc.authoridBASKIRAN, ADIL/0000-0002-7536-1631
dc.authoridAkbulut, Sami/0000-0002-6864-7711
dc.authorwosidYilmaz, Sezai/ABI-2323-2020
dc.authorwosidBASKIRAN, ADIL/ABI-2356-2020
dc.authorwosidAkbulut, Sami/L-9568-2014
dc.contributor.authorBaskiran, Adil
dc.contributor.authorAkbulut, Sami
dc.contributor.authorSahin, Tevfik Tolga
dc.contributor.authorTuncer, Adem
dc.contributor.authorKaplan, Kuntay
dc.contributor.authorBayindir, Yasar
dc.contributor.authorYilmaz, Sezai
dc.date.accessioned2024-08-04T20:10:10Z
dc.date.available2024-08-04T20:10:10Z
dc.date.issued2022
dc.departmentİnönü Üniversitesien_US
dc.description.abstractBackground: To present the struggle of a high volume liver transplant center against coronavirus infectious disease-2019 pandemic. Methods: Between March 2020 and December 2020, the demographic and clinical data of staff and liver transplant candidates diagnosed with coronavirus infectious disease-2019 in our Liver Transplant Institute were prospectively analyzed. Results: First, 32 healthcare staff were diagnosed with coronavirus infectious disease-2019, and 6 of them were surgeons. Six staff were asymptomatic, while 24 staff had mild or moderate and 2 staff had severe coronavirus infectious disease-2019. All the staff recovered from the disease without any permanent sequela and returned to duty after 2 consecutive negative polymerase chain reaction results within 24-hour intervals. Second, during the preoperative investigation, 6 living liver donor candidates and 13 recipients were tested positive for coronavirus infectious disease-2019 (son = 6, unrelated = 3, cousin = 3, daughter = 2, cadaveric = 1). Eleven patients received favipiravir and 8 did not receive any treatment because they were asymptomatic. Only one recipient who had severe coronavirus infectious disease-2019 died due to multiple organ failure syndrome. One recipient died in the early postoperative period. The median duration from the initial diagnosis of the patients till the transplant procedure was 21-days (min-max: 14-105 days). During the time of operation, the polymerase chain reaction tests of the donors and the recipients were negative, and the thorax tomography images showed no signs of viral pneumonia. Conclusion: Meticulous precautions, multidisciplinary approach, team effort, and organization of facilities can increase the quality of care of these patients in the coronavirus infectious disease-2019 era. Healthcare workers have shown tremendous effort and are the true heroes of this era.en_US
dc.identifier.doi10.5152/tjg.2022.21748
dc.identifier.endpage152en_US
dc.identifier.issn2148-5607
dc.identifier.issue2en_US
dc.identifier.pmid35115295en_US
dc.identifier.scopus2-s2.0-85125683068en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage145en_US
dc.identifier.trdizinid524298en_US
dc.identifier.urihttps://doi.org/10.5152/tjg.2022.21748
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/524298
dc.identifier.urihttps://hdl.handle.net/11616/92629
dc.identifier.volume33en_US
dc.identifier.wosWOS:000765079600021en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherAvesen_US
dc.relation.ispartofTurkish Journal of Gastroenterologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCOVID-19en_US
dc.subjectliver transplantationen_US
dc.subjectliving donor liver transplantationen_US
dc.subjectliving liver donorsen_US
dc.subjectprecautionsen_US
dc.subjectstaff safetyen_US
dc.titleCoronavirus Precautions: Experience of High Volume Liver Transplant Instituteen_US
dc.typeArticleen_US

Dosyalar